Literature DB >> 5089909

A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.

H M van Praag, J Korf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5089909

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  8 in total

1.  The biochemical evaluation of psychotropic drugs.

Authors:  A V Mackay
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 2.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.

Authors:  Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo
Journal:  J Psychiatr Res       Date:  2015-05-19       Impact factor: 4.791

3.  Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma.

Authors:  B M Emanuelsson; E Widerlöv; H Walléus; L K Paalzow
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

7.  Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.

Authors:  V Klimek; J Zak-Knapik; M Mackowiak
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

Review 8.  Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation.

Authors:  Gislaine Z Reus; Airam B de Moura; Ritele H Silva; Wilson R Resende; Joao Quevedo
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.